Recursion Pharmaceuticals (RXRX) EBIT Margin Growth (1y) (2021 - 2026)
Recursion Pharmaceuticals (RXRX) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.60 Bn | 944.55 Mn | -6.02 Mn | -68,770.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68,770.00 |
| Dec 31, 2025 | 373,757.00 |
| Sep 30, 2025 | -295,048.00 |
| Jun 30, 2025 | -21,936.00 |
| Mar 31, 2025 | -59,943.00 |
| Dec 31, 2024 | -313,405.00 |
| Sep 30, 2024 | 56,803.00 |
| Jun 30, 2024 | 4,433.00 |
| Mar 31, 2024 | -12,264.00 |
| Dec 31, 2023 | -46,246.00 |
| Sep 30, 2023 | -46,965.00 |
| Jun 30, 2023 | 12,082.00 |
| Mar 31, 2023 | 47,393.00 |
| Dec 31, 2022 | 211,864.00 |
| Sep 30, 2022 | 135,570.00 |
| Jun 30, 2022 | 74,315.00 |
| Mar 31, 2022 | 14,014.00 |
| Dec 31, 2021 | -161,393.00 |
| Sep 30, 2021 | 36,141.00 |
| Jun 30, 2021 | 818,840.00 |